Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Vulvovaginal Candidiasis (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Vulvovaginal Candidiasis (Infectious Disease) - Drugs in Development, 2021 SUMMARY Vulvovaginal Candidiasis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Vulvovaginal C...

April 2021 45 pages

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) (Oncology) - Drugs in Development, 2021 SUMMARY Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) (Oncology) - Drugs in Development,...

April 2021 160 pages

Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 or EC 2.7.10.2) - Drugs in Development, 2021

US$ 3,000.00

Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 or EC 2.7.10.2) - Drugs in Development, 2021 SUMMARY Wee1 Like Protein Kinase (Wee1A Kinase or WEE1 or EC 2.7.10.2) - Drugs in Development, 2021 provides...

April 2021 35 pages

West Nile Virus Infections (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

West Nile Virus Infections (Infectious Disease) - Drugs in Development, 2021 SUMMARY West Nile Virus Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the West Nile...

April 2021 50 pages

Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021

US$ 2,500.00

Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021 SUMMARY Wet (Neovascular / Exudative) Macular Degeneration (Ophthalmology) - Drugs in Development, 2021...

April 2021 300 pages

Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021

US$ 2,000.00

Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021 SUMMARY Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021 provides an overview of the Wilms' Tumor (Nephroblas...

April 2021 35 pages

Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021

US$ 3,000.00

Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 SUMMARY Wilms Tumor Protein (WT33 or WT1) - Drugs in Development, 2021 provides in depth analysis on Wilms Tumor Protein (WT33 or WT1) ta...

April 2021 45 pages

Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021

US$ 2,000.00

Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021 SUMMARY Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021 provides an overview of the Wiskott-Aldrich Syndrome pipel...

April 2021 30 pages

Wnt Protein (WNT) - Drugs in Development, 2021

US$ 3,000.00

Wnt Protein (WNT) - Drugs in Development, 2021 SUMMARY Wnt Protein (WNT) - Drugs in Development, 2021 provides in depth analysis on Wnt Protein (WNT) targeted pipeline therapeutics. The report provide...

April 2021 35 pages

X Linked Retinitis Pigmentosa GTPase Regulator (Retinitis Pigmentosa 15 or Retinitis Pigmentosa 3 GTPase Regulator or RPGR) - Drugs in Development, 2021

US$ 3,000.00

X Linked Retinitis Pigmentosa GTPase Regulator (Retinitis Pigmentosa 15 or Retinitis Pigmentosa 3 GTPase Regulator or RPGR) - Drugs in Development, 2021 SUMMARY X Linked Retinitis Pigmentosa GTPase Re...

April 2021 30 pages

X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021

US$ 2,000.00

X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 SUMMARY X-Linked SCID (Genetic Disorders) - Drugs in Development, 2021 provides an overview of the X-Linked SCID pipeline landscape. The...

April 2021 35 pages

Xanthine Dehydrogenase/Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) - Drugs in Development, 2021

US$ 3,000.00

Xanthine Dehydrogenase/Oxidase (Xanthine Dehydrogenase or Xanthine Oxidase or Xanthine Oxidoreductase or XDH or EC 1.17.1.4 or EC 1.17.3.2) - Drugs in Development, 2021 SUMMARY Xanthine Dehydrogenase/...

April 2021 45 pages

Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021

US$ 2,000.00

Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021 SUMMARY Xerostomia (Mouth And Dental Disorders) - Drugs in Development, 2021 provides an overview of the Xerostomia pipeline landsc...

April 2021 35 pages

Zika Virus Envelope Protein (E) - Drugs in Development, 2021

US$ 3,000.00

Zika Virus Envelope Protein (E) - Drugs in Development, 2021 SUMMARY Zika Virus Envelope Protein (E) - Drugs in Development, 2021 provides in depth analysis on Zika Virus Envelope Protein (E) targeted...

April 2021 30 pages

Zinc Finger And SCAN Domain Containing Protein 4 (Zinc Finger Protein 494 or ZSCAN4) - Drugs in Development, 2021

US$ 3,000.00

Zinc Finger And SCAN Domain Containing Protein 4 (Zinc Finger Protein 494 or ZSCAN4) - Drugs in Development, 2021 SUMMARY Zinc Finger And SCAN Domain Containing Protein 4 (Zinc Finger Protein 494 or Z...

April 2021 30 pages

Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs in Development, 2021

US$ 3,000.00

Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs in Development, 2021 SUMMARY Zinc Finger Protein GLI1 (Glioma Associated Oncogene or Oncogene GLI or GLI1) - Drugs...

April 2021 30 pages

Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021

US$ 2,000.00

Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Zygomycosis (Mucormycosis) (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Zygomycosi...

April 2021 30 pages

Pharmacogenomics: Global Markets

US$ 5,500.00

Report : This report provides an updated review of pharmacogenomics, including materials, equipment, and strategies, and identifies current and emerging applications for pharmacogenomic products. BCC...

April 2021 160 pages

Investigation Report on China's Human Serum Albumin Market 2021-2025

US$ 2,600.00

Human Serum Albumin (HSA) is made of plasma proteins from human blood, which is mainly used to replace blood volume loss resulting from trauma such as a severe burn or an injury that causes blood loss...

April 2021 50 pages

Investigation Report on China's Ibrutinib Market 2021-2025

US$ 2,600.00

Ibrutinib is a BTK inhibitor, mainly used to treat B-cell carcinomas, such as mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia. Ibrutinib was first developed by...

April 2021 40 pages

Investigation Report on China's Iodixanol Market 2021-2025

US$ 2,600.00

Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography, and so...

April 2021 50 pages

Investigation Report on China's Lenalidomide Market 2021-2025

US$ 2,600.00

Lenalidomide is an oral immunomodulatory drug that is mainly used to treat blood cancers such as multiple myeloma, myelodysplastic syndrome, and lymphoma. Lenalidomide was first developed by Celgene....

April 2021 50 pages

Investigation Report on China's Meropenem Market 2021-2025

US$ 2,600.00

Meropenem is an antibiotic that is used to treat a variety of bacterial infections, including meningitis, pneumonia and so on. Meropenem is jointly developed by Sumitomo Dainippon Pharma and Imperial...

April 2021 50 pages

Investigation Report on China's Nivolumab Market 2021-2025

US$ 2,600.00

Nivolumab is a human IgG4 monoclonal antibody that blocks PD-1, mainly used to treat non-small cell lung cancer, gastric or gastroesophageal junction adenocarcinoma, advanced renal cell carcinoma, and...

April 2021 50 pages

Investigation Report on China's Oseltamivir Market 2021-2025

US$ 2,600.00

Oseltamivir is an antiviral drug used to treat or prevent influenza virus type A and B. Oseltamivir was invented by Gilead Sciences, and Roche purchased the rights to develop and market Oseltamivir un...

April 2021 50 pages

Investigation Report on China's Osimertinib Market 2021-2025

US$ 2,600.00

Osimertinib is a small molecule targeted anti-tumor drug used to treat non-small cell lung cancer (NSCLC). The original drug, TAGRISSO was developed by AstraZeneca. Osimertinib was launched in China i...

April 2021 50 pages

Investigation Report on China's Rituximab Market 2021-2025

US$ 2,600.00

Rituximab is a monoclonal antibody to target cells that have the CD20 marker on their surface. It is mainly used to treat diseases caused by excessive B lymphocytes, including lymphoma, chronic lympho...

April 2021 50 pages

Investigation Report on China's Tacrolimus Market 2021-2025

US$ 2,600.00

Tacrolimus is a macrolide antibiotic and is also a new immunosuppressant. It is available in a variety of dosage forms. The ointment is used for moderate to severe atopic dermatitis where traditional...

April 2021 50 pages

Investigation Report on China's Trastuzumab Market 2021-2025

US$ 2,600.00

Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer, and is especially used for the treatment of certain HER-2 positive cancers. The original drug, HERCEPTIN was develo...

April 2021 50 pages

Investigation Report on Chinese Clopidogrel Market 2021-2025

US$ 2,600.00

Clopidogrel is a medication that inhibits platelet aggregation and is mainly used to prevent atherosclerotic thrombosis. The original drug, Plavix, is developed by Sanofi. It enters the Chinese market...

April 2021 50 pages

Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026

US$ 3,995.00

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vaccine Contract Manufacturing Market Report The global vaccine contract manufacturing market by revenue is...

April 2021 377 pages

ALK Inhibitors – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) 2026

US$ 2,999.00

The ALK Inhibitors – Pipeline Insights – 2018 Size, Share, Industry, Forecast and outlook (2024-2031) was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report d...

April 2021 207 pages

Investigation Report on Chinese Atorvastatin Market 2021-2025

US$ 2,600.00

... demand for Atorvastatin. TOPICS COVERED: Development environment of Atorvastatin in China Sales of Atorvastatin in China Prices of Atorvastatin in China Major Atorvastatin manufacturers in China Market share of Atorvastatin by dosage form in China Prospect of Chinese Atorvastatin Market, 2018-2022 ...

April 2021 50 pages

Investigation Report on China's Ambroxol Market, 2021-2025

US$ 2,600.00

... Pharmaceutical (Qianshan) Co., Ltd. Ambroxol is sold in China in the dosage forms of ... China Size of China's Ambroxol market Competitive landscape of China's Ambroxol market Prices of Ambroxol in China Analysis on factors affecting the development of China's Ambroxol market Prospect of China's Ambroxol ...

April 2021 50 pages

Investigation Report on China's Recombinant Lispro Insulin Market, 2021-2025

US$ 2,600.00

... market in China Market size of Recombinant Lispro Insulin in China Major Recombinant Lispro Insulin manufacturers in China Prices of Recombinant Lispro Insulin in China Major factors affecting the development of China's Recombinant Lispro Insulin market Prospect of China's Recombinant Lispro Insulin market

April 2021 50 pages

Investigation Report on China's Hydroxychloroquine Market, 2021-2025

US$ 2,600.00

Hydroxychloroquine is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine is similar to that of chloroquine. It can be rapidly absorbed in the gastrointestinal tract...

April 2021 50 pages

Investigation Report on Chinese Adalimumab Market, 2021-2025

US$ 2,600.00

In 2010, Adalimumab entered the Chinese market. Its original drug is produced by AbbVie Inc., under the brand name HUMIRA. The sales of HUMIRA is ranking at Top one among all pharmaceutical products s...

April 2021 40 pages

Investigation Report on Chinese Apixaban Market 2021-2025

US$ 2,600.00

Anticoagulation therapy plays an important role in the prevention and treatment of thromboembolic diseases. The two most famous drugs are Rivaroxaban and Apixaban, mainly used to prevent and treat ven...

April 2021 50 pages

Investigation Report on Chinese Bevacizumab Market 2021-2025

US$ 2,600.00

Bevacizumab is the world's first humanized monoclonal antibody for anti-tumor angiogenesis, which can be used to treat colon cancer and other solid tumors. AVASTIN, the original research drug (develop...

April 2021 50 pages

Investigation Report on Chinese Budesonide Market 2021-2025

US$ 2,600.00

Budesonide is an adrenal cortex hormone medicine. It is available in different forms, such as inhalant, nasal spray, and so on. The inhalation form is used to treat asthma and chronic obstructive pulm...

April 2021 50 pages

Investigation Report on Chinese Cefoperazone Sodium and Sulbactam Sodium Market 2021-2025

US$ 2,600.00

Cefoperazone Sodium and Sulbactam Sodium is an injectable antibiotic. The original drug is SULPERAZON, developed by Pfizer. In addition to Pfizer, the other main manufacturers in the Chinese market ar...

April 2021 50 pages

Investigation Report on Chinese Dezocine Market, 2021-2025

US$ 2,600.00

Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative analgesia, and preemptive analgesia....

April 2021 50 pages

Investigation Report on Chinese Pembrolizumab Market, 2021-2025

US$ 2,600.00

Pembrolizumab is a humanized PD-1 monoclonal antibody used for cancer immunotherapy. It currently has the most approved indications, as well as it is used in more tumors’ treatments than other drugs a...

April 2021 50 pages

Investigation Report on Chinese Sevoflurane Market, 2021-2025

US$ 2,600.00

Sevoflurane is an inhalation general anesthetic and also the main inhalation anesthetic at this stage. Inhaled Sevoflurane was originally developed by Abbott and entered the Chinese market in 1996. In...

April 2021 50 pages

Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)

US$ 900.00

of the Report The report titled “Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025)”, provides an in depth analysis of the global oral insulin market by value, b...

April 2021 83 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1